TY - JOUR
T1 - A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort
AU - Meda, Shashwath A.
AU - Narayanan, Balaji
AU - Liu, Jingyu
AU - Perrone-Bizzozero, Nora I.
AU - Stevens, Michael C.
AU - Calhoun, Vince D.
AU - Glahn, David C.
AU - Shen, Li
AU - Risacher, Shannon L.
AU - Saykin, Andrew J.
AU - Pearlson, Godfrey D.
N1 - Funding Information:
The study was supported by the following grants and research support to Dr. Andrew Saykin from Eli Lilly and Company , Siemens AG , Welch Allyn Inc. , the NIH ( R01 CA101318 [PI], R01 AG19771 [PI], RC2 AG036535 [Core Leader], P30 AG10133–18S1 [Core Leader], and U01 AG032984 [Site PI and Chair, Genetics Working Group]), the Indiana Economic Development Corporation ( IEDC #87884 ), and the Foundation for the NIH , and to Dr. Vince Calhoun from NIH ROIEB005846 . We would also like to thank Mrs. Joanna Mounce for assistance with the biological pathways and network analyses used in these studies.
Funding Information:
Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904 ). ADNI is funded by the National Institute on Aging , the National Institute of Biomedical Imaging and Bioengineering , and through generous contributions from the following: Abbott ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Amorfix Life Sciences Ltd .; AstraZeneca ; Bayer HealthCare ; BioClinica, Inc .; Biogen Idec Inc .; Bristol-Myers Squibb Company ; Eisai Inc .; Elan Pharmaceuticals Inc .; Eli Lilly and Company ; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc. ; GE Healthcare ; Innogenetics, N.V .; Janssen Alzheimer Immunotherapy Research & Development, LLC .; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Medpace, Inc .; Merck & Co., Inc .; Meso Scale Diagnostics, LLC .; Novartis Pharmaceuticals Corporation ; Pfizer Inc .; Servier ; Synarc Inc .; and Takeda Pharmaceutical Company . The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health ( www.fnih.org ). The grantee organization is the Northern California Institute for Research and Education , and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 , K01 AG030514 , and the Dana Foundation .
PY - 2012/4/15
Y1 - 2012/4/15
N2 - The underlying genetic etiology of late onset Alzheimer's disease (LOAD) remains largely unknown, likely due to its polygenic architecture and a lack of sophisticated analytic methods to evaluate complex genotype-phenotype models. The aim of the current study was to overcome these limitations in a bi-multivariate fashion by linking intermediate magnetic resonance imaging (MRI) phenotypes with a genome-wide sample of common single nucleotide polymorphism (SNP) variants. We compared associations between 94 different brain regions of interest derived from structural MRI scans and 533,872 genome-wide SNPs using a novel multivariate statistical procedure, parallel-independent component analysis, in a large, national multi-center subject cohort. The study included 209 elderly healthy controls, 367 subjects with amnestic mild cognitive impairment and 181 with mild, early-stage LOAD, all of them Caucasian adults, from the Alzheimer's Disease Neuroimaging Initiative cohort. Imaging was performed on comparable 1.5. T scanners at over 50 sites in the USA/Canada. Four primary "genetic components" were associated significantly with a single structural network including all regions involved neuropathologically in LOAD. Pathway analysis suggested that each component included several genes already known to contribute to LOAD risk (e.g. APOE4) or involved in pathologic processes contributing to the disorder, including inflammation, diabetes, obesity and cardiovascular disease. In addition significant novel genes identified included ZNF673, VPS13, SLC9A7, ATP5G2 and SHROOM2. Unlike conventional analyses, this multivariate approach identified distinct groups of genes that are plausibly linked in physiologic pathways, perhaps epistatically. Further, the study exemplifies the value of this novel approach to explore large-scale data sets involving high-dimensional gene and endophenotype data.
AB - The underlying genetic etiology of late onset Alzheimer's disease (LOAD) remains largely unknown, likely due to its polygenic architecture and a lack of sophisticated analytic methods to evaluate complex genotype-phenotype models. The aim of the current study was to overcome these limitations in a bi-multivariate fashion by linking intermediate magnetic resonance imaging (MRI) phenotypes with a genome-wide sample of common single nucleotide polymorphism (SNP) variants. We compared associations between 94 different brain regions of interest derived from structural MRI scans and 533,872 genome-wide SNPs using a novel multivariate statistical procedure, parallel-independent component analysis, in a large, national multi-center subject cohort. The study included 209 elderly healthy controls, 367 subjects with amnestic mild cognitive impairment and 181 with mild, early-stage LOAD, all of them Caucasian adults, from the Alzheimer's Disease Neuroimaging Initiative cohort. Imaging was performed on comparable 1.5. T scanners at over 50 sites in the USA/Canada. Four primary "genetic components" were associated significantly with a single structural network including all regions involved neuropathologically in LOAD. Pathway analysis suggested that each component included several genes already known to contribute to LOAD risk (e.g. APOE4) or involved in pathologic processes contributing to the disorder, including inflammation, diabetes, obesity and cardiovascular disease. In addition significant novel genes identified included ZNF673, VPS13, SLC9A7, ATP5G2 and SHROOM2. Unlike conventional analyses, this multivariate approach identified distinct groups of genes that are plausibly linked in physiologic pathways, perhaps epistatically. Further, the study exemplifies the value of this novel approach to explore large-scale data sets involving high-dimensional gene and endophenotype data.
KW - Enrichment
KW - Epistasis
KW - Genotype-phenotype
KW - ICA
KW - Multivariate
KW - Pathway
UR - http://www.scopus.com/inward/record.url?scp=84862817126&partnerID=8YFLogxK
U2 - 10.1016/j.neuroimage.2011.12.076
DO - 10.1016/j.neuroimage.2011.12.076
M3 - Article
C2 - 22245343
AN - SCOPUS:84862817126
SN - 1053-8119
VL - 60
SP - 1608
EP - 1621
JO - NeuroImage
JF - NeuroImage
IS - 3
ER -